Journal
CELL DEATH AND DIFFERENTIATION
Volume 23, Issue 11, Pages 1739-1748Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2016.93
Keywords
-
Categories
Funding
- Knut and Alice Wallenberg Foundation
- Russian Science Foundation [14-25-00056]
- Olle Engkvist Foundation
- Pehrssons Fund
- Russian Foundation for Basic Research
- Russian President Fund
- Stockholm Society
- Swedish Childhood Cancer Foundation
- Swedish Foundation for Strategic Research
- Swedish Research Council
- Swedish Cancer Society
- Russian Science Foundation [14-25-00056] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
Tudor staphylococcal nuclease (TSN, also known as Tudor-SN, SND1 or p100) is an evolutionarily conserved protein with invariant domain composition, represented by tandem repeat of staphylococcal nuclease domains and a tudor domain. Conservation along significant evolutionary distance, from protozoa to plants and animals, suggests important physiological functions for TSN. It is known that TSN is critically involved in virtually all pathways of gene expression, ranging from transcription to RNA silencing. Owing to its high protein-protein binding affinity coexistent with enzymatic activity, TSN can exert its biochemical function by acting as both a scaffolding molecule of large multiprotein complexes and/or as a nuclease. TSN is indispensible for normal development and stress resistance, whereas its increased expression is closely associated with various types of cancer. Thus, TSN is an attractive target for anti-cancer therapy and a potent tumor marker. Considering ever increasing interest to further understand a multitude of TSN-mediated processes and a mechanistic role of TSN in these processes, here we took an attempt to summarize and update the available information about this intriguing multifunctional protein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available